jl 18 has been researched along with Parkinsonian Disorders in 1 studies
JL 18: a pyridobenzodiazepine derivative bioisoster of clozapine
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadj Tahar, A | 1 |
| Bélanger, N | 1 |
| Bangassoro, E | 1 |
| Grégoire, L | 1 |
| Bédard, PJ | 1 |
1 other study available for jl 18 and Parkinsonian Disorders
| Article | Year |
|---|---|
Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Benserazide; Clozapine; Dose- | 2000 |